Purchase Order 75N93019P00977
Award Date 8/13/19
Potential Completion Date 8/16/20
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $23,990 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for laboratory and testing services to study protein expression in plasma samples. No set-aside was used. The contract has an ultimate completion date of September 29, 2025. Creative Biogene Inc. is a biotechnology services company that provides advanced analytical techniques, such as...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Creative Biogene Inc. for $16,630.00. The contract is for laboratory services, specifically catecholamine analysis and ADCY8 overexpression mouse cord blood services. Creative Biogene Inc. is a self-certified small disadvantaged business that provides various biotechnology services to federal agencies. There was no set-aside used for this award, and the ultimate completion date is...
- This is a $15,270.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for the provision of bovine and chicken primary epithelial cells and media, with a performance period running through February 28, 2025. This contract award does not utilize any set-aside designation. Creative Biogene has previously supported various government...
- CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New...
- This is a firm fixed-price purchase order contract awarded by the Northeast Area, a civilian agency within the U.S. federal government, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract, valued at $13,536.25, is for untargeted metabolomics analysis services. Creative Biogene has provided similar biotechnology services, including metabolomics, proteomics, and cell line development, to various federal agencies such as the U.S. Department of Agriculture, National...
- This federal contract award is for $13,190 in laboratory testing services related to plasma protein analysis associated with circadian rhythm. The contract was awarded to Creative Biogene Inc., a self-certified small disadvantaged business located in Shirley, New York. The contract is a firm-fixed-price purchase order with a completion date of November 26, 2025. The funding agency is the National Institute on Aging, which is part of the National Institutes of Health (NIH), a civilian federal...
- This $14,500.00 firm fixed-price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for quantitative proteomics analysis services to support NIAAA research initiatives, with a period of performance through December 31, 2024. No set-aside was used for this award. Creative Biogene has previously...
- This is a $19,980.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Cancer Institute to Creative Biolabs Inc. for laboratory testing services. The contract has a period of performance from May 15, 2024 to July 10, 2024 and does not have a set-aside designation. Creative Biolabs Inc. is a for-profit organization that specializes in providing custom biotechnology and pharmaceutical services to support federal...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- Creative Biolabs Inc. has been awarded a $18,180 purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide LPS analysis services. The contract has a period of performance from September 18, 2023 through December 31, 2023 and utilizes a firm fixed price payment structure. Work will be conducted by Creative Biolabs' division in Hamilton, Montana to support the NIH/NIAID's research efforts. No major subcontractors or set aside...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Creative Biogene Inc., a self-certified small disadvantaged business, for the delivery of custom gene knockout cell lines. The potential value of the contract is $15,000.00, and the period of performance ends on August 16, 2020. Creative Biogene has a history of providing specialized biotechnology services, including metabolomics analysis, proteomics research, cell line development, and mass spectrometry, to various federal agencies such as the USDA, NIH, and DoD.
Generated 6/1/24, 11:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 8/13/19 |